|
BMS1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.099920E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.282500E-02 |
| Normal-vs-Stage2 |
5.542200E-01 |
| Normal-vs-Stage3 |
1.527790E-01 |
| Normal-vs-Stage4 |
4.803200E-01 |
| Stage1-vs-Stage2 |
7.398000E-01 |
| Stage1-vs-Stage3 |
5.822600E-01 |
| Stage1-vs-Stage4 |
8.746000E-01 |
| Stage2-vs-Stage3 |
5.092200E-01 |
| Stage2-vs-Stage4 |
7.271800E-01 |
| Stage3-vs-Stage4 |
8.686600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.016400E-02 |
| Normal-vs-AfricanAmerican |
8.520300E-02 |
| Normal-vs-Asian |
5.840000E-02 |
| Caucasian-vs-AfricanAmerican |
9.412600E-01 |
| Caucasian-vs-Asian |
1.299600E-01 |
| AfricanAmerican-vs-Asian |
1.151360E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.334950E-01 |
| Normal-vs-Female |
2.365400E-04 |
| Male-vs-Female |
2.057000E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
7.678600E-01 |
| Normal-vs-Extreme_Weight |
3.733400E-01 |
| Normal-vs-Obese |
1.622500E-02 |
| Normal-vs-Extreme_Obese |
8.970800E-01 |
| Normal_Weight-vs-Extreme_Weight |
6.888400E-01 |
| Normal_Weight-vs-Obese |
1.014600E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.819000E-01 |
| Extreme_Weight-vs-Obese |
1.450760E-01 |
| Extreme_Weight-vs-Extreme_Obese |
6.064600E-01 |
| Obese-vs-Extreme_Obese |
2.086600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.611500E-04 |
| Normal-vs-Age(41-60Yrs) |
3.795800E-03 |
| Normal-vs-Age(61-80Yrs) |
1.954010E-01 |
| Normal-vs-Age(81-100Yrs) |
9.237600E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.750490E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.968900E-04 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.155800E-04 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.553600E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.555500E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.449700E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.623500E-03 |
| Normal-VS-Type2 PRCC |
6.355400E-01 |
| Normal-VS-KIRP CIMP |
8.178900E-03 |
| Normal-VS-Unclassified PRCC |
6.436200E-02 |
| Type1 PRCC-VS-Type2 PRCC |
3.041000E-03 |
| Type1 PRCC-VS-KIRP CIMP |
1.027720E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
7.112400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
9.609500E-04 |
| Type2 PRCC-VS-Unclassified PRCC |
3.239900E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
9.877900E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.565600E-01 |
| Normal-vs-N1 |
1.486280E-02 |
| Normal-vs-N2 |
4.198000E-01 |
| N0-vs-N1 |
3.957400E-03 |
| N0-vs-N2 |
1.502210E-01 |
| N1-vs-N2 |
9.641000E-01 |
|
|
